This editorial focuses on the synergistic effects of phytochemicals, particularly quercetin and triptolide, in treating liver cancer. It comments on the study by Tong HX et al. in WJG. The article's topic is interesting, scientifically valuable, and has potential for clinical translation. It covers the anti-tumor mechanisms of phytochemicals, signaling pathway regulation, microRNA intervention, and connections to traditional Chinese medicine,